Holen Sie sich die Stockscreener-App
5.43
2.65%
0.14
Vorhandelsmarkt:
5.48
0.05
+0.92%
Candel Therapeutics Inc Aktie (CADL) Neueste Nachrichten
Candel Therapeutics, Inc. (NASDAQ:CADL) Given Average Rating of "Buy" by Analysts - MarketBeat
Candel Therapeutics, Inc. $CADL Shares Purchased by Halter Ferguson Financial Inc. - MarketBeat
Candel Therapeutics (NASDAQ:CADL) Rating Increased to Hold at Wall Street Zen - MarketBeat
Candel Therapeutics Inc. stock volume spike explainedGap Up & Safe Entry Trade Signal Reports - newser.com
Aug Setups: Should I hold or sell Candel Therapeutics Inc nowJuly 2025 Weekly Recap & Technical Pattern Based Signals - khodrobank.com
Aug Setups: Can Candel Therapeutics Inc beat the S P 500Market Rally & Low Risk Growth Stock Ideas - خودرو بانک
Should you hold or exit Candel Therapeutics Inc. nowJuly 2025 Institutional & Real-Time Stock Movement Alerts - newser.com
Using Python tools to backtest Candel Therapeutics Inc. strategiesJuly 2025 Momentum & Accurate Trade Setup Notifications - newser.com
Is now a turning point for Candel Therapeutics Inc.Portfolio Update Report & Free Daily Entry Point Trade Alerts - newser.com
Is Candel Therapeutics Inc. stock bottoming outWeekly Risk Report & AI Powered Market Entry Strategies - newser.com
Analyzing Candel Therapeutics Inc. with risk reward ratio chartsPortfolio Value Summary & Daily Stock Trend Watchlist - newser.com
New Highs: Will Candel Therapeutics Inc face regulatory challengesJobs Report & Scalable Portfolio Growth Ideas - خودرو بانک
Candel Therapeutics to Present Phase 3 Results of CAN-2409 in Localized Prostate Cancer at ASTRO 2025 - GlobeNewswire
Ranking Candel Therapeutics Inc. among high performing stocks via toolsShare Buyback & AI Powered Market Trend Analysis - newser.com
Candel Therapeutics to present Phase 3 CAN-2409 data at ASTRO 2025 - Proactive financial news
H.C. Wainwright Maintains Candel Therapeutics(CADL.US) With Buy Rating, Maintains Target Price $23 - 富途牛牛
Candel Therapeutics, Inc. Announces Oral Presentation of CAN-2409 Data at 2025 ASTRO Annual Meeting - Quiver Quantitative
Major Phase 3 Prostate Cancer Treatment Results: Candel's CAN-2409 Data Coming to ASTRO Conference - Stock Titan
S P Trends: Will Candel Therapeutics Inc face regulatory challengesMarket Rally & Accurate Entry/Exit Alerts - خودرو بانک
Aug Sentiment: Can Candel Therapeutics Inc. expand its profit marginsPortfolio Value Report & Weekly High Conviction Trade Ideas - خودرو بانک
Published on: 2025-09-17 04:59:57 - khodrobank.com
Aug Momentum: What is Candel Therapeutics Inc.’s valuation compared to sector2025 Major Catalysts & Safe Entry Zone Identification - خودرو بانک
Aug Mood: Is Candel Therapeutics Inc stock forming a triangle pattern2025 Trade Ideas & AI Forecast Swing Trade Picks - khodrobank.com
Trend Review: What are Candel Therapeutics Inc.’s earnings expectationsWeekly Loss Report & Expert Approved Momentum Ideas - خودرو بانک
Sentiment Recap: Can Candel Therapeutics Inc. beat the S&P 500Market Performance Report & Safe Entry Point Identification - خودرو بانک
Acorn Capital Advisors LLC Has $12.16 Million Stock Holdings in Candel Therapeutics, Inc. $CADL - MarketBeat
Candel Therapeutics Inc. stock trendline breakdownWeekly Investment Recap & Capital Efficient Trading Techniques - newser.com
Candel Therapeutics (NASDAQ:CADL) Stock Rating Lowered by Wall Street Zen - MarketBeat
Nuveen LLC Makes New $442,000 Investment in Candel Therapeutics, Inc. $CADL - MarketBeat
Candel Therapeutics (NASDAQ:CADL) Lowered to Neutral Rating by Bank of America - MarketBeat
Candel Therapeutics: Potentially The Next Exciting Oncology Story - Seeking Alpha
Baker BROS. Advisors LP Cuts Holdings in Candel Therapeutics, Inc. $CADL - MarketBeat
Can Candel Therapeutics Inc. be recession proofQuarterly Performance Summary & Weekly Setup with ROI Potential - 뉴스영
What MACD and RSI say about Candel Therapeutics Inc.July 2025 Earnings & Low Risk Entry Point Guides - Newser
How volatile is Candel Therapeutics Inc. stockWeekly Market Outlook & Smart Allocation Stock Tips - 더경남뉴스
Can Candel Therapeutics Inc. expand its profit marginsWeekly Trend Report & Real-Time Market Sentiment Alerts - خودرو بانک
What is Candel Therapeutics Inc.’s valuation compared to sectorEarnings Recap Report & Real-Time Volume Surge Alerts - خودرو بانک
Dow Update: Is Candel Therapeutics Inc. benefiting from interest rate changesTake Profit & Verified Technical Signals - خودرو بانک
Will Candel Therapeutics Inc. benefit from macro trendsWeekly Trade Summary & Reliable Intraday Trade Plans - Newser
Pattern recognition hints at Candel Therapeutics Inc. upsideTrade Volume Summary & Precise Buy Zone Identification - Newser
Insider Purchases Worth US$3.00m See Losses As Candel Therapeutics Market Value Drops To US$280m - 富途牛牛
Advanced analytics toolkit walkthrough for Candel Therapeutics Inc.2025 Market Outlook & Weekly High Momentum Picks - Newser
Should I average down on Candel Therapeutics Inc. stockRate Cut & Free Real-Time Market Sentiment Alerts - خودرو بانک
Candel Therapeutics: Revolutionizing Solid Tumor Treatment with Viral Immunotherapies - AInvest
Candel Therapeutics: Oncolytic Immunotherapy Showing Broad Efficacy In Tough Tumors - Seeking Alpha
What are Candel Therapeutics Inc.’s earnings expectationsPortfolio Performance Summary & Free Verified High Yield Trade Plans - خودرو بانک
How to track smart money flows in Candel Therapeutics Inc.Share Buyback & Consistent Return Strategy Ideas - Newser
Chart based analysis of Candel Therapeutics Inc. trendsJuly 2025 Market Mood & AI Forecasted Stock Moves - Newser
Candel Therapeutics Inc. stock daily chart insights2025 Market Overview & Long-Term Growth Portfolio Plans - Newser
1.30%
2.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):